Aileron Therapeutics Stock Quote ALRN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.77

Bid

3.60

Ask

4.20

Volume

25,714

3.48 Day's Range 3.71

1.01 52 Week Range 7.42

Market Cap

18.125M

Previous Close

3.69

Open

3.62

Last Trade

3.61

Last Trade Time

Financial Volume

$ 92,998

VWAP

3.6166

Average Volume (3m)

96,174

Shares Outstanding

4,885,512

Dividend Yield

PE Ratio

-1.15

Earnings Per Share (EPS)

-3.22

Revenue

Net Profit

-15.73M

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aileronrx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aileron Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALRN. The last closing price for Aileron Therapeutics was $3.69. Over the last year, Aileron Therapeutics shares have traded in a share price range of $ 1.01 to $ 7.42.

Aileron Therapeutics currently has 4,885,512 shares outstanding. The market capitalization of Aileron Therapeutics is $18.13 million. Aileron Therapeutics has a price to earnings ratio (PE ratio) of -1.15.

Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million

AUSTIN, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (“Aileron”) (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1	-2.58397932817	3.87	4	3.48	35033	3.83388418	CS
4	-0.97	-20.4641350211	4.74	5.43	3.28	117097	4.20288885	CS
12	-0.84	-18.2212581345	4.61	7.42	3.28	96174	4.83905709	CS
26	1.93	104.891304348	1.84	7.42	1.7469	99147	4.52452419	CS
52	2.44	183.458646617	1.33	7.42	1.01	66347	3.74344907	CS
156	-20.23	-84.2916666667	24	28	1.01	309554	10.55261087	CS
260	-18.03	-82.7064220183	21.8	49.4	1.01	625200	22.81005485	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MGOLMGO Global Inc	$ 1.21 (426.32%)	337.52M
MGRXMangoceuticals Inc	$ 0.5113 (102.09%)	238.68M
BDRXBiodexa Pharmaceuticals PLC	$ 2.34 (84.25%)	125.65M
BRLSBorealis Foods Inc	$ 7.1101 (77.75%)	3.99M
CSLRComplete Solaria Inc	$ 1.87 (59.83%)	3.1M
CTNTCheetah Net Supply Chain Service Inc	$ 1.17 (-92.07%)	93.38M
GWAVGreenwave Technology Solutions Inc	$ 0.05865 (-62.88%)	709.76M
LUXHLuxUrban Hotels Inc	$ 0.2605 (-42.11%)	10.74M
CRKNCrown Electrokinetics Corporation	$ 0.1256 (-36.88%)	323.44M
BCGBinah Capital Group Inc	$ 2.70 (-35.71%)	10.37k
GWAVGreenwave Technology Solutions Inc	$ 0.05865 (-62.88%)	709.76M
MGOLMGO Global Inc	$ 1.21 (426.32%)	337.52M
CRKNCrown Electrokinetics Corporation	$ 0.1256 (-36.88%)	323.44M
MGRXMangoceuticals Inc	$ 0.5113 (102.09%)	238.68M
FFIEFaraday Future Intelligent Electric Inc	$ 1.3611 (-24.38%)	228.35M